These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis. Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434 [TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
11. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis. Ibrahim SH; Gores GJ; Hirsova P; Kirby M; Miles L; Jaeschke A; Kohli R Liver Int; 2014 Mar; 34(3):427-37. PubMed ID: 24256559 [TBL] [Abstract][Full Text] [Related]
12. Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials. Brunt EM; Kleiner DE; Wilson LA; Sanyal AJ; Neuschwander-Tetri BA; Hepatology; 2019 Aug; 70(2):522-531. PubMed ID: 30549292 [TBL] [Abstract][Full Text] [Related]
13. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686 [TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. Møllerhøj MB; Veidal SS; Thrane KT; Oró D; Overgaard A; Salinas CG; Madsen MR; Pfisterer L; Vyberg M; Simon E; Broermann A; Vrang N; Jelsing J; Feigh M; Hansen HH Clin Transl Sci; 2022 May; 15(5):1167-1186. PubMed ID: 35143711 [TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease. Christensen CU; Glavind E; Thomsen KL; Kim YO; Heebøll S; Schuppan D; Hamilton-Dutoit S; Würtz Heegaard C; Grønbæk H PLoS One; 2018; 13(3):e0192728. PubMed ID: 29522534 [TBL] [Abstract][Full Text] [Related]
16. Vertical Sleeve Gastrectomy Attenuates the Progression of Non-Alcoholic Steatohepatitis in Mice on a High-Fat High-Cholesterol Diet. Whang E; Liu Y; Kageyama S; Woo SL; Yang J; Lee R; Li Z; Ji H; Chen Y; Kupiec-Weglinski JW Obes Surg; 2019 Aug; 29(8):2420-2429. PubMed ID: 30982168 [TBL] [Abstract][Full Text] [Related]
17. [Influence of High-fat and High-cholesterol Diet on Major CYP Activities in the Liver]. Suzuki S; Sato Y; Umegaki K; Chiba T Yakugaku Zasshi; 2016; 136(9):1297-305. PubMed ID: 27592832 [TBL] [Abstract][Full Text] [Related]
18. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204 [TBL] [Abstract][Full Text] [Related]
19. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145 [TBL] [Abstract][Full Text] [Related]
20. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis. Bril F; Barb D; Lomonaco R; Lai J; Cusi K J Hepatol; 2020 Mar; 72(3):401-410. PubMed ID: 31589891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]